Doxorubicin translocation B7-H1 from the cell surface to the nucleus of breast cancer cells: A novel role for B7-H1 as an anti-apoptotic molecule

Hematology/ Oncology and Stem Cell Therapy

Volumn 3, Issue 3, 2010, Pages 163-

  Abdelsalam, Mahmoud ^a  

^a Kasr Alainy Hospital   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; CD274 PROTEIN, HUMAN; DOXORUBICIN; LEUKOCYTE ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

APOPTOSIS; CELL MEMBRANE; CELL NUCLEUS; DRUG EFFECT; FEMALE; HUMAN; LETTER; METABOLISM; PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD; APOPTOSIS; CELL LINE, TUMOR; CELL MEMBRANE; CELL NUCLEUS; DOXORUBICIN; FEMALE; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 79952279748     PISSN: 16583876     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1658-3876(10)50028-1     Document Type: Letter

References (10)

1. Zang, X., Allison, J.P., The B7 family and cancer therapy: costimulation and coinhibition. Clin Cancer Res 13 (2007), 5271–5279.
2. Ghebeh, H., Barhoush, E., Tulbah, A., Elkum, N., Al-Tweigeri, T., Dermime, S., FOXP3 + Tregs and B7-H1 +/ PD-1 + T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy. BMC Cancer, 8, 2008, 57.
3. Ghebeh, H., Tulbah, A., Mohammed, S., Elkum, N., Bin Amer, S.M., Al-Tweigeri, T., Dermime, S., Expression of B7-H1 in breast cancer patients is strongly associated with high proliferative Ki-67-expressing tumor cells. Int J Cancer 121 (2007), 751–758.
4. Ghebeh, H., Mohammed, S., Al-Omair, A., Qattan, A., Lehe, C., Al-Qudaihi, G., Elkum, N., Alshabanah, M., Bin Amer, S., Tulbah, A., Ajarim, D., Al-Tweigeri, T., Dermime, S., The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia 8 (2006), 190–198.
5. Weiss, R.B., The anthracyclines: will we ever find a better doxorubicin?. Semin Oncol 19 (1992), 670–686.
6. EBCTCG, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365 (2005), 1687–1717.
7. Apetoh, L., Mignot, G., Panaretakis, T., Kroemer, G., Zitvogel, L., Immunogenicity of anthracyclines: moving towards more personalized medicine. Trends Mol Med 14 (2008), 141–151.
8. Ghebeh, H., Lehe, C., Barhoush, E., Al-Romaih, K., Tulbah, A., Al-Alwan, M., Hendrayani, S.F., Manogaran, P., Al-Tweigeri, T., Alaiya, A., Aboussekhra, A., Dermime, S., Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule. Breast Cancer Res, 12, 2010, R48.
9. Crane, C.A., Panner, A., Murray, J.C., Wilson, S.P., Xu, H., Chen, L., Simko, J.P., Waldman, F.M., Pieper, R.O., Parsa, A.T., PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer. Oncogene 28 (2009), 306–312.
10. Parsa, A.T., Waldron, J.S., Panner, A., Crane, C.A., Parney, I.F., Barry, J.J., Cachola, K.E., Murray, J.C., Tihan, T., Jensen, M.C., Mischel, P.S., Stokoe, D., Pieper, R.O., Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat Med 13 (2007), 84–88.